0.1886

5.36% 0.0096

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

VolitionRX Ltd stock is traded at $0.1886, with a volume of 1.22M. It is up +5.36% in the last 24 hours and down -34.81% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$0.179

Open:

$0.18

24h Volume:

1.22M

Relative Volume:

0.69

Market Cap:

$5.67M

Revenue:

$2.47M

Net Income/Loss:

$-24.73M

P/E Ratio:

-0.0448

EPS:

-4.213

Net Cash Flow:

$-20.36M

1W Performance:

-14.04%

1M Performance:

-34.81%

6M Performance:

-94.49%

1Y Performance:

-97.86%

1-Day Range:

$0.178

$0.194

1-Week Range:

$0.1748

$0.23

52-Week Range:

$0.1748

$10.31

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1051)

Industry

Medical Devices (143)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2026-11-12

Latest SEC Filings

VNRX's Discussions on Twitter

Compare VNRX vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VNRX VolitionRX Ltd	0.1886	5.67M	2.47M	-24.73M	-20.36M	-4.213
ABT Abbott Laboratories	104.47	180.77B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	95.28	121.88B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	291.70	111.89B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.77	63.43B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.59	49.91B	6.30B	1.07B	1.09B	1.8406

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-25	Initiated	H.C. Wainwright	Buy
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

Sep 30, 2026

Neither party sold shares as VolitionRx (VNRX) retained 284 shares for its commercial chief’s taxes. - Stock Titan

Sep 30, 2026

No shares were sold as VolitionRx (VNRX) retained 608 COO shares for cancellation to cover taxes. - Stock Titan

Sep 30, 2026

Sep 22, 2026

VolitionRx stock faces a data driven trading reset - AD HOC NEWS

Sep 22, 2026

Lagoda Investment Management, L.P. Trims VolitionRX Ltd (VNRX) S - GuruFocus

Sep 22, 2026

Sep 18, 2026

VolitionRx Limited stock edges higher as investors weigh recent results - AD HOC NEWS

Sep 18, 2026

Sep 17, 2026

VolitionRx Limited Shares Further Details On The Official Launch Of The DETECSEPS Project On The Early Detection Of Sepsis - marketscreener.com

Sep 17, 2026

VolitionRx joins France sepsis detection consortium By Investing.com - Investing.com Nigeria

Sep 17, 2026

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - PR Newswire

Sep 17, 2026

VolitionRx Participates in Launch of DETECSEPS Program in France - PR Newswire

Sep 17, 2026

A €6.3 million French program will test one blood marker to spot sepsis early - Stock Titan

Sep 17, 2026

Sep 16, 2026

One manager now reports nearly 6% of VolitionRx (NYSE: VNRX) - Stock Titan

Sep 16, 2026

Sep 14, 2026

VolitionRx Limited (AMEX:VNRX) Prepays $7.5M Convertible Note, Cuts Dilution Risk - TradingView

Sep 14, 2026

VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - Yahoo Finance

Sep 14, 2026

VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in t - Yahoo Finance

Sep 14, 2026

VolitionRX Limited Announces Pre-Payment in F - Moomoo

Sep 14, 2026

Sep 11, 2026

VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan

Sep 11, 2026

Sep 10, 2026

Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus

Sep 10, 2026

VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus

Sep 10, 2026

A blood-based method detected 95% of stage I and II cancers. - Stock Titan

Sep 10, 2026

Sep 09, 2026

Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan

Sep 09, 2026

Sep 08, 2026

VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan

Sep 08, 2026

Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - kalkinemedia.com

Sep 08, 2026

VNRX - Finviz

Sep 08, 2026

Sep 04, 2026

Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake - tradingview.com

Sep 04, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga

Aug 27, 2026

$VolitionRX (VNRX.US)$ - Moomoo

Aug 27, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Yahoo Finance

Aug 27, 2026

Aug 26, 2026

VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade

Aug 26, 2026

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance

Aug 26, 2026

Volition's sepsis biomarker predicts 28-day death and kidney treatment needs - Stock Titan

Aug 26, 2026

Aug 17, 2026